AYI Stock Analysis: Acuity Brands | NYSE
Electrical Equipment & Parts | NYSE, USA | Market Cap: 9.264m USD | 12M Return: -9.8% | US00508Y1029 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 88.1M
EPS Trend: 98.6%
Qual. Beats: 0
Rev. Trend: 87.7%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Acuity Inc. (NYSE: AYI) is an Atlanta-headquartered industrial company that designs and manufactures lighting, lighting controls, building management systems, and audio/video/control platforms for customers in the United States and abroad. It operates through two segments: Acuity Brands Lighting (ABL), which sells luminaires and lighting components under a large portfolio of proprietary brands (such as Lithonia Lighting, Juno, Gotham, and Holophane) to electrical distributors, retailers, and OEM customers; and Acuity Intelligent Spaces (AIS), which delivers connected building management and AV solutions under the Atrius, Distech Controls, QSC, and KE2 Therm Solutions brands to venues including retail stores, airports, universities, enterprise campuses, sports venues, and hospitality properties. The company was incorporated in 2001 and changed its name from Acuity Brands, Inc. to Acuity Inc. in March 2025.
Classified within the GICS Industrials sector under Electrical Components & Equipment, Acuity generates roughly $9.3 billion in market capitalization as a mid-cap issuer, and its business model centers on selling engineered, branded lighting fixtures and integrated building systems through distribution and system-installer channels rather than competing as a low-cost commodity supplier.
- Non-residential construction slowdown pressures ABL lighting demand
- AIS segment margins expand on QSC audio platform integration
- LED pricing competition from imports compresses lighting margins
| Net Income: 472.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 2.89 > 1.0 |
| NWC/Revenue: 18.02% < 20% (prev 18.94%; Δ -0.92% < -1%) |
| CFO/TA 0.16 > 3% & CFO 722.7m > Net Income 472.3m |
| Net Debt (499.4m) to EBITDA (794.9m): 0.63 < 3 |
| Current Ratio: 2.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (31.0m) vs 12m ago -1.94% < -2% |
| Gross Margin: 49.31% > 18% (prev 47.40%; Δ 1.91% > 0.5%) |
| Asset Turnover: 99.26% > 50% (prev 89.72%; Δ 9.54% > 0%) |
| Interest Coverage Ratio: 17.82 > 6 (EBIT TTM 630.7m / Interest Expense TTM 35.4m) |
| A: 0.18 (Total Current Assets 1.62b - Total Current Liabilities 788.3m) / Total Assets 4.64b |
| B: 1.00 (Retained Earnings 4.63b / Total Assets 4.64b) |
| C: 0.14 (EBIT TTM 630.7m / Avg Total Assets 4.64b) |
| D: 1.60 (Book Value of Equity 2.85b / Total Liabilities 1.78b) |
| Altman-Z'' = 7.02 = AAA |
| DSRI: 0.91 (Receivables 610.9m/608.6m, Revenue 4.61b/4.17b) |
| GMI: 0.96 (GM 47.40% / 49.31%) |
| AQI: 0.97 (AQ_t 0.56 / AQ_t-1 0.57) |
| SGI: 1.10 (Revenue 4.61b / 4.17b) |
| TATA: -0.05 (NI 472.3m - CFO 722.7m) / TA 4.64b) |
| Beneish M = -3.08 (Cap -4..+1) = AA |
As of October 01, 2026, the stock is trading at USD 309.81 with a total of 629,869 shares traded. Over the past week, the price has changed by +1.23%, over one month by -6.62%, over three months by -17.70% and over the past year by -9.82%.
Current recommended Stop Loss: 292.10 (which is 5.7% or 1.8 ATR below the current price).
Acuity Brands has received a consensus analysts rating of 4.11. Therefore, it is recommended to buy AYI.
- StrongBuy: 4
- Buy: 2
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 398.3 | 28.6% |
P/E Trailing = 20.5478
P/E Forward = 14.1044
P/S = 2.011
P/B = 3.2131
P/EG = 1.2104
Revenue TTM = 4.61b USD
EBIT TTM = 630.7m USD
EBITDA TTM = 794.9m USD
Long Term Debt = 697.3m USD (from longTermDebt, last quarter)
Short Term Debt = 27.0m USD (from shortTermDebt, last quarter)
Debt = 911.3m USD (from shortLongTermDebtTotal, last quarter) + Leases 107.0m
Net Debt = 499.4m USD (calculated: Debt 911.3m - CCE 411.9m)
Enterprise Value = 9.76b USD (9.26b + Debt 911.3m - CCE 411.9m)
Interest Coverage Ratio = 17.82 (Ebit TTM 630.7m / Interest Expense TTM 35.4m)
EV/FCF = 15.27x (Enterprise Value 9.76b / FCF TTM 639.4m)
FCF Yield = 6.55% (FCF TTM 639.4m / Enterprise Value 9.76b)
FCF Margin = 13.88% (FCF TTM 639.4m / Revenue TTM 4.61b)
Net Margin = 10.25% (Net Income TTM 472.3m / Revenue TTM 4.61b)
Gross Margin = 49.31% ((Revenue TTM 4.61b - Cost of Revenue TTM 2.33b) / Revenue TTM)
Gross Margin QoQ = 50.62% (prev 49.29%)
Tobins Q-Ratio = 2.11 (Enterprise Value 9.76b / Total Assets 4.64b)
Interest Expense / Debt = 3.88% (Interest Expense 35.4m / Debt 911.3m)
Taxrate = 21.07% (126.1m / 598.4m)
NOPAT = 497.8m (EBIT 630.7m * (1 - 21.07%))
Current Ratio = 2.05 (Total Current Assets 1.62b / Total Current Liabilities 788.3m)
Debt / Equity = 0.32 (Debt 911.3m / totalStockholderEquity, last quarter 2.85b)
Debt / EBITDA = 0.63 (Net Debt 499.4m / EBITDA 794.9m)
Debt / FCF = 0.78 (Net Debt 499.4m / FCF TTM 639.4m)
Total Stockholder Equity = 2.80b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.18% (Net Income 472.3m / Total Assets 4.64b)
RoE = 16.85% (Net Income TTM 472.3m / Total Stockholder Equity 2.80b)
RoCE = 18.02% (EBIT 630.7m / Capital Employed (Equity 2.80b + L.T.Debt 697.3m))
RoIC = 13.66% (NOPAT 497.8m / Invested Capital 3.64b)
WACC = 11.17% (E(9.26b)/V(10.2b) * Re(11.97%) + D(911.3m)/V(10.2b) * Rd(3.88%) * (1-Tc(0.21)))
Discount Rate = 11.97% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -44.40 | Cagr: -0.63%
[DCF] Terminal Value 69.40% ; FCFF base≈586.2m ; Y1≈672.0m ; Y5≈989.0m
[DCF] Fair Price = 314.6 (EV 9.92b - Net Debt 499.4m = Equity 9.42b / Shares 29.9m; r=11.17% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.62 | EPS CAGR: 12.79% | SUE: 0.57 | # QB: 0
Revenue Correlation: 87.66 | Revenue CAGR: 7.60% | SUE: 1.04 | # QB: 1
EPS current Quarter (2026-11-30): EPS=5.09 | Chg30d=+0.00% | Revisions=+50% | Analysts=6
EPS current Year (2026-08-31): EPS=19.83 | Chg30d=+0.00% | Revisions=+36% | GrowthEPS=+10.1% | GrowthRev=+7.0%
EPS next Year (2027-08-31): EPS=21.69 | Chg30d=+0.00% | Revisions=+73% | GrowthEPS=+9.4% | GrowthRev=+5.0%
[Analyst] Revisions Ratio: +68% (up=17, down=2)